Read + Share
Munoz-Vendrell A, Arroyo-Pereiro P, Leon I, Bau L, et al. Natalizumab continuation versus switching to ocrelizumab after PML risk
stratification in RRMS patients: a natural experiment. J Neurol 2023;270:2559-2566.
PMID: 36913038
|
 |
|
Munoz-Vendrell A, Arroyo-Pereiro P, Leon I, Bau L, et al. Natalizumab continuation versus switching to ocrelizumab after PML risk
stratification in RRMS patients: a natural experiment. J Neurol 2023;270:2559-2566.
PMID: 36913038
|
|
|
|